Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis

NCT07310914 · tracked via the Priya Life Science Ireland tracker

Sponsor

Danish Multiple Sclerosis Hospitals

Phase

Phase 2

Started

2026-02-01

Last updated

2025-12-30

Condition(s) studied

Multiple Sclerosis

Investigational drug(s) / intervention(s)

TelerehabilitationPaper-based exercise

Telerehabilitation: Advanced telerehabilitation with a program made by specialized physiotherapists and delivered through the WizeCare system.

Paper-based exercise: Paper-based exercise instructions made by specialized physiotherapists.

Study summary

The overall purpose of the present study is to investigate the effect of an advanced telerehablitation system (TRS) in persons with multiple sclerosis on mobility. The advanced telerhabilitation system is based on AI components, and delivers instant feedback to the partcipants. If the project is successful, it can help optimize exercise for those persons with multiple sclerosis who are either not able or willing to travel to a clinical setting for exericse.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Definite diagnosis of MS according to the McDonald criteria (both relapse-remitting and progressive) * Expanded Disability Status Scale (EDSS) score of 2.5 to 6.5 or Patient Determined Disability Score (PDDS) of 2 to 6, indicating preservation of at least some ambulatory function, that is, the ability to walk 20 meters or more, independently, with or without the use of an assistive device * Willingness to travel to the local study site for the evaluation sessions, * Internet platform availability Exclusion Criteria: * comorbidities hindering participation in the study. * Individuals who have had a documented relapse and/or corticoid treatment during the past three months will be excluded, * Individuals with severe cognitive deficits who cannot follow simple instructions and/or consent.

Primary outcome measure(s)

30 second sit to stand test — Baseline to 10 weeks
Measure of lower extremity muscle power and a proxy measure of mobility

Trial sites (5)

Facility	City	Region
The Danish MS Hospitals, Haslev	Haslev	Denmark
The Danish MS Hospitals, Ry	Ry	Denmark
MS Ireland	Dublin	Ireland
Tel Aviv University	Tel Aviv	Israel
University of Cagliari	Cagliari	Italy

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07310914 on ClinicalTrials.gov ↗ ← All trials in Ireland